Dementia prevention, intervention, and care: 2020 report of the Lancet Commission

G Livingston, J Huntley, A Sommerlad, D Ames… - The Lancet, 2020 - thelancet.com
Executive summary The number of older people, including those living with dementia, is
rising, as younger age mortality declines. However, the age-specific incidence of dementia …

Type 2 diabetes and cognitive dysfunction—towards effective management of both comorbidities

V Srikanth, AJ Sinclair, F Hill-Briggs… - The lancet Diabetes & …, 2020 - thelancet.com
Type 2 diabetes and cognitive dysfunction are highly prevalent disorders worldwide.
Although type 2 diabetes is associated with an increased risk of dementia, awareness of the …

Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019

E Nichols, JD Steinmetz, SE Vollset… - The Lancet Public …, 2022 - thelancet.com
Background Given the projected trends in population ageing and population growth, the
number of people with dementia is expected to increase. In addition, strong evidence has …

[PDF][PDF] World Alzheimer Report 2016. Improving healthcare for people living with dementia: Coverage, Quality and costs now and in the future.

M Prince, A Comas-Herrera, M Knapp, M Guerchet… - 2016 - unilim.hal.science
There are currently no disease modifying treatments for dementia, which is a life-limiting
illness, and deaths with dementia are increasingly common. In the World Alzheimer Report …

Adverse childhood experiences (ACEs) and substance use disorder (SUD): a scoping review

L Leza, S Siria, JJ López-Goñi… - Drug and alcohol …, 2021 - Elsevier
Background The long-term negative effects of adverse childhood experiences (ACEs) and
their impact on physical and mental health has been widely studied. However, research …

Multimorbidity and functional impairment–bidirectional interplay, synergistic effects and common pathways

A Calderón‐Larrañaga, DL Vetrano… - Journal of internal …, 2019 - Wiley Online Library
This review discusses the interplay between multimorbidity (ie co‐occurrence of more than
one chronic health condition in an individual) and functional impairment (ie limitations in …

Neuropsychiatric symptoms in elderly with dementia during COVID-19 pandemic: definition, treatment, and future directions

A Simonetti, C Pais, M Jones, MC Cipriani… - Frontiers in …, 2020 - frontiersin.org
Background Neuropsychiatric symptoms (NPS) of dementia, such as anxiety, depression,
agitation, and apathy, are complex, stressful, and costly aspects of care, and are associated …

Association between sarcopenia and cognitive impairment: a systematic review and meta-analysis

KV Chang, TH Hsu, WT Wu, KC Huang… - Journal of the American …, 2016 - Elsevier
Background Sarcopenia, a gradual loss of muscle mass and function, has been associated
with poor health outcomes. Its correlation with another age-related degenerative process …

Forecasting the care needs of the older population in England over the next 20 years: estimates from the Population Ageing and Care Simulation (PACSim) modelling …

A Kingston, A Comas-Herrera, C Jagger - The Lancet Public Health, 2018 - thelancet.com
Background Existing models for forecasting future care needs are limited in the risk factors
included and in the assumptions made about incoming cohorts. We estimated the numbers …

A systematic review of medication non-adherence in persons with dementia or cognitive impairment

D Smith, J Lovell, C Weller, B Kennedy, M Winbolt… - PloS one, 2017 - journals.plos.org
Background Adherence to medication is vital for disease management while simultaneously
reducing healthcare expenditure. Older persons with cognitive impairment (CI) are at risk for …